Massimo De Giorgio, Stefano Vezzoli, Eric Cohen, Elia Armellini, Maria Grazia Lucà, Giulianna Verga, Domenico Pinelli, Roberto Nani, Maria Grazia Valsecchi, Laura Antolini, Michele Colledan, Stefano Fagiuoli, Mario Strazzabosco – 8 February 2010 – Transplantation is the treatment of choice for hepatocellular carcinoma (HCC) meeting the Milan criteria. HCC and chronic liver diseases have distinct natural histories for which an equitable transplant policy must account.

Shin Hwang, Sung‐Gyu Lee, Chul‐Soo Ahn, Deok‐Bog Moon, Ki‐Hun Kim, Kyu‐Bo Sung, Gi‐Young Ko, Tae‐Yong Ha, Gi‐Won Song, Dong‐Hwan Jung, Dong‐Il Gwon, Kyoung‐Won Kim, Nam‐Kyu Choi, Kwan‐Woo Kim, Young‐Dong Yu, Gil‐Chun Park – 8 February 2010 – The incidence of clinically significant right hepatic vein (RHV) stenosis after adult living donor liver transplantation has been higher than expected. In this study, an assessment of the risk factors for the development of RHV stenosis in this context was undertaken.

Jean F. Botha, Alan N. Langnas, B. Daniel Campos, Wendy J. Grant, Christopher E. Freise, Nancy L. Ascher, David F. Mercer, John P. Roberts – 8 February 2010 – Adult‐to‐adult living donor liver transplantation (AA‐LDLT) has better outcomes when a graft weight to recipient weight ratio (GW/RW) > 0.8 is selected. A smaller GW/RW may result in small‐for‐size syndrome (SFSS). Portal inflow modulation seems to effectively prevent SFSS. Donor right hepatectomy is associated with greater morbidity and mortality than left hepatectomy.

Dinesh Jothimani, Timothy J. S. Cross – 8 February 2010

Chia‐Chi Wang, Jia‐Horng Kao – 28 January 2010

Kenji Nakayama, Mamoru Tamura – 28 January 2010

Alberto Quaglia, Ahlam Mustafa, Ragai R. Mitry, Bernard Portmann – 28 January 2010

Manuel Romero‐Gómez, Moisés Diago, Raúl J. Andrade – 28 January 2010

Rebecca G. Wells – 27 January 2010

Ismail Ben Mosbah, Joan Roselló‐Catafau, Izabel Alfany‐Fernandez, Antoni Rimola, Pera Puig Parellada, Maria Teresa Mitjavila, Antonin Lojek, Hassen Ben Abdennebi, Olivier Boillot, Juan Rodés, Carmen Peralta – 26 January 2010 – Here we examine the effect of adding carvedilol (CVD) to University of Wisconsin (UW) solution on the preservation of steatotic and nonsteatotic livers during cold ischemia and after normothermic reperfusion. We used an isolated perfused rat liver model. The following protocols were evaluated. Protocol 1 concerned the effect of CVD after cold ischemia.